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ABSTRACT
THE EFFECT OF ARGININE VASOTOCIN ON CRYOPROTECTANT
PRODUCTION DURING FREEZING IN
THE PACIFIC CHORUS FROG,
Pseudacris regilla
by
Ben Ingels
February 2017
Freeze Tolerance is an adaptation seen amongst several species of amphibians as
a way of surviving during wintering months. Use of cryoprotectants is seen in all freeze
tolerant species (glucose/glycerol). Synthesis and transportation mechanisms that regulate
this process are not yet fully understood. Arginine vasotocin is a neurohypophyseal
peptide known to have glycogenolytic effects as well as regulate several key processes
involved in fluid and solute transportation. Although one prior study suggested that AVT
is not involved in responses to freezing, I measured AVT levels during freezing and
injected an AVT antagonist to see if it would affect the production of cryoprotectants
within liver and thigh muscle during freezing. There was a dramatic increase in systemic
AVT levels (p=0.05) during freezing by Pseudacris regilla. The AVT antagonist caused a
dramatic reduction (~50%) in hepatic glucose and glycerol concentrations. These results
demonstrate that AVT is involved with the process of cryoprotectant sourcing during
freezing events in Pseudacris regilla.
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CHAPTER I
INTRODUCTION
Winter in the inland Pacific Northwest exposes animals to harsh, cold conditions,
including subzero temperatures for extended periods of time. Life has developed many
strategies to adapt to such conditions. For warm-blooded or endothermic animals, the
choices are numerous. Some indigenous species, such as shorebirds and caribou, choose
to simply migrate to more favorable environments. Others, such as silver-haired bats and
hummingbirds (Carpenter and Hixon, 1988; Falxa, 2007), have developed physiological
adaptations that allow them to temporarily lower their metabolic rate and core
temperature to avoid excessive heat loss and conserve energy, a process known as torpor.
Hibernation is a strategy able to extend this decrease in metabolic activity/body
temperature for extended periods of time (Marchand, 2013).
For ectotherms, which are dependent on environmental heat, the choices are more
limited. Exposure to cold, and the near unavoidable contact with ice, brings a series of
challenges for survival. Ice formation is detrimental to life in many ways: it can cause
physical damage to the cell by intruding through cellular structures, can cause cellular
dehydration by loss of fluids to the growing ice crystals and denature proteins (Muldrew
and McGann, 1988). Other osmoregulatory processes can be adversely affected by ice
formation. For example, dissolved solutes are excluded from growing ice crystals which
may result in harmful accumulations within the unfrozen fluids (Muldrew and McGann,
1988).
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Certain amphibians living within these northern regions have developed a novel
adaptation of tolerating the freezing of body fluids within the organism to survive
(Schmid, 1982), an adaptation referred to as freeze tolerance. Currently, freeze tolerance
has been observed in 12 amphibian species. These include the Gray Treefrog (Hyla
versicolor and H. chrysoscelis), the Wood Frog (Rana sylvatica) and the Pacific Chorus
Frog (Pseudacris regilla) (Schmid, 1982; Croes and Thomas, 2000; Costanzo et al.,
2013). The Siberian Salamander Salamandrella keyserlingii, and the Schrenck newt
Salamandrella schrenckii, have also been documented as having this unique adaptation
(Berman et al., 2009). During freezing, cardiac, respiratory and brain activity cease or
severely decrease (Storey and Storey, 1988; Costanzo et al., 1995). These functions
reanimate upon thawing, with full function returning in one to four days (Costanzo et al.,
1995; Irwin et al., 2002).
Understanding the mechanisms behind freeze tolerance reveals the use of specific
low-density molecules (glucose, glycerol, urea) as cryoprotectants to preserve cell/organ
integrity, limit absolute dehydration and control ice formation within the organism
(Costanzo et al., 1992; Storey and Storey, 1992, 1996). The ability to endure massive
organ/tissue dehydration is also observed in these freeze-tolerant amphibians. During
freezing, organs may lose up to 60% of their fluid content, largely due to the formation of
ice crystals (Lee et al., 1992). As the cells dehydrate, intracellular solute concentrations
increase dramatically, resulting in an effective decrease in freezing temperature, reducing
and controlling ice formation (Lee et al., 1992).
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Cryoprotectants
The use of cryoprotectants to aid in the survival of freezing has been observed in
all freeze-tolerant amphibians. Amphibians demonstrating freeze tolerance use glucose
and glycerol as the main substrates for cryoprotection (Storey and Storey, 1996). Ice
formation initiates a sudden and rapid increase in the synthesis of these cryoprotectants,
which are assumed to be primarily sourced from liver glycogen (Storey and Storey,
1996). Muscle glycogen is generally preserved for localized metabolic needs and lacks
the necessary enzymes to convert their stores into free glucose for systemic use (Van
Shaftingen, 2002). These liver glycogen stores are built up prior to the wintering period
(Storey and Storey, 1996). Once inoculated with ice through skin contact, the liver begins
a rapid breakdown of glycogen to build up cryoprotectant levels and disperse them to the
tissues through the bloodstream (Costanzo et al., 1992).
Cryoprotectants aid in protecting and stabilizing cell membranes from ice
damage, and aid in the osmotic regulation required during freezing (Amaral et al., 2015).
As cells begin to lose their fluids to ice in extracellular spaces, the concentration of
cryoprotectants in and around the cell increases. This change creates an osmotic gradient
that prevents complete dehydration and allows ice formation to occur at a pace slow
enough for cellular stability and regulation to occur (Costanzo and Lee, 1994; Croes and
Thomas, 2000; Healas, 2014). Ice sheets begin to form around tissues and within the
abdominal/lymphatic cavities where up to 70% of the total body water can be locked up
in ice crystals (Layne and Lee, 1987). The sequestration of ice in the lymphatic spaces
helps to limit the amount of ice forming in other areas where physical damage to organs
3

and tissue could occur (Lee and Costanzo, 1998). Urea may also play a protective role in
amphibians by guarding the osmotic concentration, stabilizing cell membranes, cell
structures and macromolecules (Storey and Storey, 2004; Costanzo and Lee, 2008).
Amphibians accumulate urea under times of inadequate environmental water as a means
of combating dehydration (Jørgenson, 1997). Dehydration due to ice accumulation should
therefore trigger a very similar osmotic stress response. In experiments with the wood
frog Rana sylvatica, frogs exposed to high levels of urea saw a dramatic increase in both
cell/tissue survivability in vitro as well as increased recovery time of neuromuscular
functions (Costanzo and Lee, 2008). More research is needed to understand the extent of
urea accumulation during freezing, variations between freeze-tolerant species and to what
degree of protection urea offers during freezing.

Pacific Chorus Frog; Pseudacris regilla
The Pacific Chorus Frog, Pseudacris regilla (formerly Hyla regilla), is a species
that has a range that extends from central British Columbia to Baja California. These
frogs are found as far east as Montana and Nevada and all along the West Coast
(Duellman and Sweet, 1999; Stebbins, 2003). It was first reported as freeze tolerant in
2000 (Croes and Thomas, 2000). P. regilla has been observed overwintering beneath leaf
litter, where it is exposed to weather conditions (Irwin, unpub. data). Limited studies
have examined the freezing ability of P. regilla across its range, but it has been observed
that Washington State sea-level populations share the same level of tolerance as higher
elevation populations (Healas, 2014). Glucose and glycerol concentrations seem to vary
4

amongst populations of P. regilla, which could be linked to local adaptations, but more
research is needed in this area (Healas, 2014).

Glycogen, Glucose, Glycerol: Sources of Cryoprotectants
There are several biochemical pathways by which cryoprotectants may be
produced (Fig 1.1). The first step of glucose production is glycolysis: the break-down of
glycogen to free D-glucose (10% net) and a large amount of glucose-1-phosphate (90%
net) (Gerin and Van Shaftingen, 2002). The enzyme involved in this process is glycogen
phosphorylase, which acts to break the α1-4 glycosidic bond of the glycogen chain via
phosphorylation, giving an end-product of glucose-1 phosphate. Glycogen debranching
enzyme then acts as a transferase on the α1-4 glycosidic bond, as well as influencing
glucosidase activity on the α1-6 glycosidic bonds via hydrolysis, leaving an end-product
of unbound D-glucose. The third enzyme involved in glycogenolysis is
phosphoglucomutase, which converts glucose-1-phosphate to the more widely used
glucose-6-phosphate. Within the liver, glucose-6-phosphate interacts with glucose-6phosphatase (G6Pase) to produce free D-glucose. G6Pase is unique, being a membranebound enzyme found within liver and kidney endoplasmic reticulum (Gerin and Van
Shaftingen, 2002).
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Figure 1.1 Glycogenolysis overview: Debranching enzyme’s hydrolytic α1-6 glucosidase activity
creates free D-glucose (10% net). Glucose-6-phosphotase is unique and found strictly in the liver to
convert G6P into free glucose. Muscle glycogen is strictly used for localized metabolic demands,
where G1P is free to enter Krebs cycle for ATP synthesis

The initiation of freezing (via inoculation by ice) has been shown to increase the
concentration of glucose in both the blood and liver of amphibians (Storey and Storey,
1996). Within four minutes of the detection of ice formation, liver and blood glucose
levels rose to 3-6fold within the species Rana sylvatica. This study concluded that the
stimulation of glucose release is a result of extracellular signaling mediated by β6

adrenergic receptors within the plasma membrane of hepatocytes (Storey and Storey,
1996). Glycogen phosphorylase activity is stimulated by hormones such as epinephrine
and glucagon, both of which increase cAMP levels and trigger cAMP-dependent protein
kinase, PKA (Dieni et al., 2011). The β-adrenergic-blocker propranolol prevents the
release of glucose in frozen frogs, whereas the α-adrenergic blocker phentolamine had no
effect on glycogenolytic activity or glucose output (Storey and Storey, 1996). This
finding is more evidence the mechanism of release of glucose is mediated via βadrenergic reception (Storey and Storey, 1996; Dieni et al., 2011), linked to a cAMP
intracellular messenger system.

Aquaporins
Aquaporins (AQPs) are a family of proteins that form selective water channels
within the plasma membranes of various cells within the organism (Ogushi et al., 2010).
A subgroup of AQPs act to help facilitate the transportation of small solutes such as
glycerol and urea through selective pores. This family is known as glyceroporins or
aquaglyceroporins (GLPs) (Zimmerman et al., 2006; Ogushi et al., 2010). The discovery
of AQPs was in the 1990s (Agre et al., 1993); although they were previously speculated
to exist (Brown et al., 1980; De Sousa and Grosso, 1982). AQPs have been observed
across a myriad of taxa; ranging from bacteria to vertebrates (Suzuki et al., 2007).
Within amphibians, specifically, 20 AQPs cDNAs have been identified and exist
in six clusters with two being unique to the amphibians (Suzuki et al., 2007). Amphibian
AQPs are expressed in the epithelium of the vasculature along the pelvic patch skin,
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urinary bladder, and within the kidney (Tanii et al., 2002; Hasegawa et al., 2003; Ogushi
et al., 2010). Epinephrine and AVT have been shown to regulate several families of
AQPs/GLPs within amphibians (Ogushi et al., 2007; Ratycz, 2014).

Arginine Vasotocin (AVT)
Arginine vasotocin (AVT), one of two peptides released by the neurohypophysis
in amphibians (Boyd, 2006), is homologous to arginine vasopressin in mammals. AVT
has a variety of effects in amphibians, including osmoregulation, behavior/reproduction,
and cardiovascular regulations. The osmoregulatory actions of AVT are on several key
organs including the kidney, bladder and skin. AVT acts on the skin by increasing the
water permeability by regulating expression of aquaporins within the epithelium,
specifically in the ventral pelvic area (Hasegawa, 2003). Within the kidney, AVT causes
vasoconstriction of preglomerular arteries which reduces glomerular filtration rates by as
much as 85% (Boyd, 2006). In the bladder, AVT acts to stimulate movement of water
from the bladder back into the plasma and is accompanied by the increased expression of
aquaporins (Jo and Harris, 1995). AVT has also been observed to increase levels of cAMP
through impacted tissues (Janssens et al., 1985; Jo and Harris, 1995).
There are three main receptor subtypes identified for AVT in the amphibian
(Boyd, 2012). The VT1aR is specific for AVT and closely mirrors the V1a Vasopressin
receptor found in mammals. The VT1bR differs from its VT1aR counterpart in its
exclusive expression in the brain and pituitary gland. This subtype closely resembles the
V1b Vasopressin receptor in mammals. Both of these subtypes have been shown to
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couple with the protein kinase-C mediated signaling pathway (Boyd, 2012). The other
vasotocin receptor type, VT2R, has a high affinity for AVT (Boyd, 2006) and is most
similar to the V2 Vasopressin receptor in mammals. Unlike the VT1 receptors, VT2R
uses a cAMP signaling pathway (Boyd, 2012). Hydrins are believed to be variants of proAVT processing and play key roles in fluid absorption/reabsorption in the skin and
bladder (Michel et al., 1993).
AVT has also been shown to stimulate glycogenolysis within the liver and
increases the activity of glycogen phosphorylase α activity and cAMP (Ade, et al.,1995;
Boyd, 2006). AVT stimulates glycogenolysis via VT2R receptor activation (Janssens et
al., 1986). Research has also shown insulin can inhibit this AVT-induced glycogenolysis
through reduction of cAMP levels within axolotl livers (Janssens and Grigg, 1992).
Preliminary research has also shown the AVT V1a/V2 receptor antagonist, β-Mercapto-β,
βcyclopenta-methylenepropionyl1-, O-ET-Tyr2, (Val, Arg8)) Vasopressin, reduced liver
glucose levels in frozen Pacific Chorus Frogs (Pense, 2011).
To date, there has been a lack of research in understanding AVT’s role in
cryoprotectant release and regulation during freezing in freeze-tolerant amphibians. In
this study, I first wanted to verify Croes and Thomas’s findings that P. regilla was a
freeze-tolerant species utilizing glucose and glycerol as cryoprotectants. I also wanted
confirm my suspicions that AVT plays a role in the freeze-tolerance by seeing if there was
an elevation in systemic AVT during freezing. I then wanted to see how cryoprotectant
accumulation would be affect if the effect of AVT was inhibited during freezing.
Measuring systemic levels of AVT during freezing would be a first, and provide an
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evidence base for the theory AVT is involved during freezing. By measuring glucose and
glycerol concentrations from hepatic and muscular tissues during freezing in both a
control group and an AVT inhibited group, I would gain powerful insight into how AVT
impacts cryoprotectant accumulation during freezing. I suspected to see elevations of
AVT during freezing. I also expected suppressing AVT within freezing frogs would
suppress accumulations of cryoprotectants as well.
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CHAPTER II
MATERIALS/METHODS
Specimen Collection/Storage

I collected frogs from two sites: Stampede Pass, Washington (GPS: 47°18'36.4"N
121°18'13.6"W) and Table Mountain, Washington (GPS: 47º 14’ 36.4” N 120º
33’33.4”W). Frogs were collected during August-September by hand and net. I held frogs
in a secured vinyl-outdoor enclosure (8x12x24ft), with small mesh sub-enclosures
(3x3x3ft). The enclosures were located at Engelhorn pond on the campus of Central
Washington University. Frogs were fed ad libitum on mineral powder-dusted crickets
twice weekly. Dead or ill frogs were immediately removed from the enclosures. On
December 5th (before weather was cold enough to induce freezing), I relocated frogs into
plastic box enclosures containing substrate and leaf litter sourced from the outdoor
enclosure area. Enclosures were stored in a climate-controlled 4°C storage room. Once
indoors, frogs began a fasting period and remained in these conditions until experiments
began in February or March. All procedures were performed and done with approval by
the CWU Institutional Animal Care and Use Committee (protocol number A031505).

Experimental Design

Male frogs were chosen at random and split evenly into control or experimental
groups. I injected all frogs in the dorsal lymph sac with either 10µL of physiological
saline (control group) or 10µL of 5mg/mL AVT-Antagonist (β-Mercapto-β, βcyclopenta11

methylenepropionyl1-, O-ET-Tyr2, (Val, Arg8)) vasopressin (Sigma V4253) in
physiological saline (experimental group). This compound is a potent antagonist for the
V1a and V2 AVT receptors. Once injected, I placed the frogs in 50mL centrifuge tubes
along with a small amount of ice to induce inoculation and a soft-foam plug was inserted
to immobilize specimen. Tubes were then placed into an ice bath and held for 30mins
prior to freezing.
Freezing Protocol
I placed the 50ml centrifuge tubes with the ice-inoculated frogs into a computercontrolled ethanol bath (Thermo RTE-740) pre-cooled to 0.5ºC. I used a real-time
temperature data logger (Omega DAQPRO5300) probe placed into one control frog tube
to monitor temperature around the frog. Temperature was then cooled to -0.8°C, after
which a controlled cooling rate of -0.04°C·h-1 was maintained until a temperature of 2.5°C was reached. The frogs were held at this temperature for four hours, then removed
from the bath and immediately dissected to remove liver and femoral muscles. Liver and
thigh musculature were weighed and subsamples were removed and weighed to
determine water content. The tissues and the carcass were then stored at -80°C until
needed for physiological analyses.

AVT Immunoassay Extraction Preparation
Frozen and unfrozen frogs were removed from storage at -80ºC were used for the
AVT Immunoassay. I removed and weighed any large visible ice crystals from abdomen
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of each frog. Decapitation of each frog at the base of the occipital condyles was
performed to ensure only systemic AVT levels were measured and no pituitary stores
would be calculated into my results. The remaining carcasses were frozen using liquid
nitrogen and ground to a fine uniform powder with a mortar and pestle. Tissues were
prepared using an enzymatic extraction kit (Peninsula Labs product #S-5000) on ~750mg
of carcass powder, initially homogenized in 3mL Buffer A solution (1% trifluoroacetic
acid). I then spun down the homogenate at 13.5k, 2ºC for 30minutes and collected the
supernatant and froze overnight. Once the supernatant was thawed, it was centrifuged at
13.5k for 10 minutes. I extracted 800ml of the new supernatant and ran it through SEPcolumn filters and washed per instructions. The eluent from each filter was freeze dried
for 48hours, then reconstituted with 500µL EIA buffer. This solution was used to
determine circulating AVT levels in the Immunoassay.

AVT Immunoassay Protocol
Immunoassay was performed using instructions provided by Peninsula Lab’s
AVT-EIA Kit (Product # S-1239.0001). I added 50µL of either EIA buffer solution,
standard, or sample to each well of a pretreated 96-well plate, followed by25µL of
antiserum and a one hour incubation at room temperature. 25µL of rehydrated Bt-tracer
in EIA buffer was added to each well and given an additional two-hour incubation. The
plate was carefully washed and dried with 300µL of EIA buffer five times before
receiving 100µL of streptavidin-HRP in each well, followed by a 60-minute incubation.
The wash washed five times, 100µL of TMB-solution added and allowed incubate for an
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additional 45 minutes. Samples were read at 540µm wavelength (Turner SP-870
spectrophotometer), then again at one hour at 450µm wavelength after the addition of
100µL 2N hydrochloric acid.

Metabolite Assay Preparation
I homogenized liver and thigh musculature in ice-cold 0.6 mol·L-1 perchloric acid
in 2mL micro-centrifuge tubes, then spun at 13.5k for 5 minutes before being neutralized
with 1mol·L-1 potassium bicarbonate. I extracted the supernatant from each tube and
placed it in a new, labelled -80°C-safe micro-centrifuge tube. As sample of the raw
homogenate was placed in a labeled, -80ºC-safe micro-centrifuge tube for measurement
of glycogen content. All other samples were placed in a -80ºC cold storage until needed
for assays.

Free glucose Assay
I measured glucose using an assay kit (Sigma-Aldrich, product no. GAGO-20).
Assays involved adding 50uL of the tissue extract to 1mL PGO-solution in a 2.0mL
cuvette and allowing it to react for 45mins in darkness. I read absorbance at 450µm
(Turner SP-870 spectrophotometer) and calculated glucose concentration was calculated
based on comparison to a standard of known concentration (400mg/L).
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Glycogen Assay
Glycogen assays were performed on100µL aliquotes of raw homogenate
neutralized with 50µL of 1mol·L-1 potassium bicarbonate. I then added 500µL of a 1:39
aspergillus-enzymatic digest solution (Sigma Aldrich, CAS 9032-08-0) to the tubes and
incubated for 2 hours at 40ºC. After which I added 250µL of 0.6N perchloric acid
followed by 375µL 1mol·L-1 potassium bicarbonate. Tubes were centrifuged at 13.5k rpm
for 10 minutes and analyzed using the Sigma-Aldrich free-glucose assay kit GAGO-20 as
described above. Glucose levels obtained from this assay, minus the results of the freeglucose test gave us the total new glycogen concentration. I tested the efficiency of the
glycogen digest by using 55mg of bovine glycogen to 2.5mL of 0.6N perchloric acid and
assaying the glycogen concentration using the same procedures as used for glycogen
assay for tissues described above, I saw a ~99% efficiency rate.

Glycerol Assay
Glycerol was measured using the free-glycerol reagent kit from Sigma-Aldrich
(catalog no. F6428). I added 50µL of ultra-purified water, glycerol standard, or extracted
supernatant to 800µl of free-glycerol reagent in appropriately labeled 2mL centrifuge
tubes. Samples were then incubated for 15mins at ambient temperature. Iread the samples
at 540nm and compared it to standards of known concentration (200mg/L).
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Statistical Analysis
All data were log-transformed for statistical analysis to pass normality and equalvariance testing. Welch’s 2 sample t-tests were performed to look at differences between
control and experimental groups, whereas analysis of covariance (ANCOVA) with
bodyweight as the covariate was run to account for differences in body size amongst
samples. All tests were performed in MiniTab 17.
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CHAPTER III
RESULTS
Mean bodyweights (Fig 2.1) were not significantly different between control and
experimental frogs (t = 0.07, df=14, p= 0.949). Control frogs showed a mean bodyweight
of 3.69 ± 0.37g (n=8) while my AVT-antagonist treatment group averaged 3.65 ± 0.42g
(mean ± SEM, n=9). This being the case, differences seen in cryoprotectant were not
influenced by bodysize.

5.00
4.50

Mean body weight (g)

4.00
3.50
3.00
2.50
2.00
1.50
1.00
0.50
0.00

Control

Experimental

Figure 2.1 Mean bodyweight from control and AVT-antagonist treatment P. regilla.

Cryoprotectant Results
While investigating glucose production, the AVT-antagonist group produced
~50% of the glucose in liver samples compared to control frogs (Fig 2.2). Control frogs
showed a mean glucose level of 703±66µMol/g dry mass (n=8) while my AVT17

antagonist frogs showed a concentration of 364±68µMol/g dry mass (n=9). This
difference of mean hepatic glucose levels between control and the antagonist treated
group was statistically significant (t= 3.58, df=14, p= 0.003).
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Liver Glucose (µMol/g dry mass)
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Figure 2.2 Mean hepatic glucose from control and AVT-antagonist treatment P.
regilla.

This trend did not hold true, however, within thigh samples (Fig 2.3). Free glucose
levels within the AVT-antagonist treated group were not significantly different from the
control in the thigh samples (t= -0.36, df=10, p= 0.728). Control frogs averaged
26±6µMol/g dry mass (n=8). Amongst my AVT-antagonist treated group, mean thigh
glucose levels measured 28±3µMol/g dry mass (n=9).
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Figure 2.3 Mean thigh glucose from control and AVT-antagonist treatment P. regilla.

Hepatic glycerol levels of the AVT-antagonist frogs showed a 40% reduction
compared to control frogs (Fig 2.4). Control frogs showed a mean hepatic glycerol level
of 5.1±0.8µMol/g dry mass (n=8), AVT-antagonist group 3.2±0.7µMol/g dry mass (n=9).
Liver glycerol production was significantly influenced by body size as well (f= 12.06,
df=1, p=0.004). Thigh glycerol levels (Fig 2.5) showed no significant difference between
control and AVT-antagonist groups (t=1.21, df=1, p=0.247). Control value for thigh
glycerol were 3.2±0.6µMol/g dry mass (n=8). AVT-antagonist values 2.2±0.5µMol/g dry
mass (n=9). Bodyweight contributed significantly to glycerol levels as well, with larger
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frogs producing larger amounts of glycerol (f= 7.15, df=1, p = 0.019).
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Figure 2.4 Mean hepatic glycerol concentrations from control and AVT-antagonist
treatment P.regilla.

I found mean hepatic glycogen levels within control frogs of 644.6±234.2µMol/g
dry mass (n=8) (Fig. 2.6). In my AVT-antagonist group, values produced a mean of
676.6±171.1µMol/g dry mass (n=9). These results produced no significant difference.
Knowing that muscular glycogen is utilized primarily for localized energy demands as it
lacks the G6Pase enzyme (Gerin and Van Shaftingen, 2002), I felt it was unnecessary to
measure glycogen content within thigh samples.
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AVT Immunoassay results
I observed that frozen frogs had over double the measurable AVT levels over
unfrozen control frogs (0.42±0.1 ng/g vs. 1.04 ±0.65ng/g; t=0.05, p=0.05) (Fig. 2.7).
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Figure 2.5 Mean thigh glycerol concentrations from control and AVT-antagonist
treatment P.regilla.
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Figure 2.6 Mean hepatic glycogen from control and AVT-antagonist treatment P.
regilla
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Figure 2.7 Mean AVT concentration from unfrozen control and frozen P. regilla
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CHAPTER IV
DISCUSSION
Freezing and Cryoprotectant Accumulation in Pseudacris regilla
Freeze-tolerant amphibians use glucose and glycerol as cryoprotectants to combat
the stressors associated with freezing (i.e., ice formation, dehydration: Storey and Storey
1996; Irwin and Lee, 2003; Costanzo et al., 2013). Freezing drives up hepatic glucose
levels nearly 20-fold in Hyla versicolor and Hyla chrysoscelis (Irwin and Lee, 2003). In
Rana sylvatica hepatic glucose levels went from ~3µMol/g wet wt. to 236µMol/g wet wt.
with freezing (Storey and Storey, 1996). Similarly, a Northern California population of P.
regilla exhibited a 5 to11-fold increase in liver glucose levels during freezing, with levels
reaching ~100µMol/g wet wt. (Croes and Thomas, 2000). I saw even higher hepatic
glucose levels, reaching ~266µMol/g wet wt. (Fig. 2.2). My results are comparable to
cryoprotectant accumulation with several other known species of freeze-tolerant
amphibians, suggested that the glucose produced in cryoprotective as it is in other
amphibian species.
Because glycogen is the dominate source of glucose, I measured the glycogen
content within P.regilla and compared it to previous works. I saw similar patterns as in
previous investigations, with my population showing a mean glycogen level of around
245µMol/g wet wt. (Fig. 2.6) and Californian P. regilla producing 362µMol/g wet wt.
(Croes and Thomas, 2000). Seasonal and geographical variations in glycogen stores have
been well documented within amphibians, including those known to be freeze-tolerant
and other members of the genus Pseudacris (Pinder et al., 1992; Dismore and Swanson,
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2008; Costanzo et. al., 2013). Knowing that variation is likely to be seen with different
populations of P. regilla, seeing a marginal variation like I did between my finding vs.
Croes and Thomas would be likely and would not suggest any less capacity for freeze
tolerance.
Croes and Thomas’s study also noted a 2 to 3-fold increase in glycerol, another
cryoprotectant used by freeze-tolerant amphibians (Zimmerman et al., 2007). My results
showed glycerol accumulations around one third of that seen in the work of Croes and
Thomas with P. regilla reaching only 1.92µMol/g wet wt (5.10µMol/g dry wt) (Fig. 2.4).
Again, seasonal and geographical variation may very well explain the difference
measured by Croes and Thomas vs. my findings within P. regilla.

Arginine Vasotocin, Freezing and Cryoprotectants
The concentration of circulating AVT levels has never been studied in freezetolerant amphibians. In this current study, I measured a significant increase in systemic
AVT levels within frozen Pseudacris regilla. Frozen frogs had more than double the
systemic AVT levels of control frogs (0.42ng/g vs. 1.04ng/g) (Fig. 2.7). This supports my
hypothesis that AVT is involved during freezing, and is the first experiment to show an
elevation of AVT during freezing in any freeze-tolerant amphibian.
Although never directly measured before, there was much reason to predict that
freezing would increase AVT concentrations. Studies have shown internal organs lose up
to 60% of their water content during freezing (Lee et al., 2002) which would activate
physiological responses to dehydration like the release of AVT. For example, frogs and
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axolotls elevate in systemic AVT when faced with osmotic stress events like dehydration
(Maejima et al., 2008; Uchiyama et al., 2014). AVT affects water movement by acting on
the permeability of tissues throughout the body, including the integumentary and urinary
systems (Tanii et al., 2002; Hasegawa et al., 2003; Suzuki et al., 2006; Ogushi et al.,
2010). Several families of aquaporins are directly mediated by AVT as well (Suzuki et al.,
2006). Aquaporins affect the movement of not only water, but small solutes such as
glycerol and urea. It has already been seen in several freeze-tolerant species that glycerol
elevations occur during freezing (Croes and Thomas, 2000; Zimmerman et al., 2007). It
has also been observed that elevations of AVT-mediated aquaporins do occur during
freezing (Zimmerman et al., 2007). Freezing would induce both osmoregulatory
challenges the need for cryoprotectants, both of which could be provided by AVT. Indeed,
my results confirm this hypothesis: AVT increases during freezing and is likely being
used to stimulate cryoprotectant production and movement, along with its involvement in
osmoregulation.
My study is the first to observe a direct relationship between AVT and
cryoprotectant accumulation during freezing. Under influence of the AVT antagonist, I
saw a dramatic decrease in hepatic glucose concentrations (702.6 vs. 363.8 µMol/g dry
wt).. This is consistent with other studies demonstrating the glycogenolytic effects of
AVT in amphibians (Janssens et al., 1985; Ade et. al., 1995). This effect is linked to AVT
increasing the activity of glycogen phosphorylase (GP), the initiating enzyme of
glycogenolysis (Ade et al., 1995; Boyd, 2006).
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AVT also plays a role in glycerol production. The AVT antagonist reduced
glycerol accumulation within the liver by~40% from 5.1 to 3.1 µMol/g dry wt. Glycerol
can be obtained through two mechanisms, glycolysis or lipolysis. There is no research to
date that has measured the extent to which each pathway is involved with regards to total
glycerol output during freezing in amphibians. This study, as well as others, have already
shown glucose production is affected by AVT during freezing within P. regilla. Glycerol
production may also be bound by same relationship, as glucose and glucose 6-phosphate
are precursors in the glycolytic production of glycerol.
Glycerol movement may also be influenced by AVT. Glycerol must be allowed to
travel through cells to necessary areas to play its cryoprotective role, and the movement
of glycerol is in large part facilitated by AQPs/GLPs under regulatory control by AVT
(Boyd, 2006; Suzuki et al., 2006; Krane and Goldstein, 2007; Ogushi et al., 2010).
Without upregulation of these necessary transportation mechanisms, it is likely the
movement of glycerol could also be directly influenced by AVT. It is also possible this
could be a factor in the reduction of total hepatic glycerol levels seen in my AVT
antagonist-treatment frogs. With AVT inhibited, both production and movement of
glycerol can be effected and again I measured a significant reduction in hepatic glycerol
under these conditions.
I hypothesized that liver glycogen levels would be higher after exposure to the
AVT antagonist, as these frogs would use less glycogen to produce the lower levels of
cryoprotectants observed. Mean glycogen levels for control frozen frogs came in at
644.6±234.2µMol/g dry mass, while AVT-antagonist treated frogs produced
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676.6±171.1µMol/g dry mass. The lack of statistical difference in glycogen levels seen in
my results is likely due to the natural variation seen amongst individuals. It is clear AVT
does play a role in cryoprotectant accumulation during freezing in P. regilla and further
investigation into understating the biochemical/physiological processes involved
certainly are merited.

AVT, Epinephrine & cAMP signaling
Epinephrine (β-adrenergic) activity has also been documented in influencing the
levels of cryoprotectant accumulation in various freeze-tolerant species (Ade et al., 1995;
Storey and Storey, 1996; Amaral et al., 2015). Similar studies have also shown that with
the use of propranolol, a β-adrenergic antagonist, frogs saw a significantly reduced
accumulation of hepatic glucose during freezing (236µMol/g wet wt. vs 130µMol/g wet
wt.)(Storey and Storey, 1996). This reduction is in hepatic glucose is very similar to that
observed within my AVT-antagonist group. The rise in glycogenolysis through increased
AVT-mediated, GP activity has been shown to be linked directly to an increase in cAMP
concentration within the tissues (Ade et al., 1995; Janssens et al., 1985). Indeed, in both
AVT and β-adrenergic activation of glycogenolysis, the cAMP intracellular pathway
mediates glycogenolysis (Janssens and Grigg, 1992). Similarly, I speculate that AVT is
acting along with epinephrine to influence cAMP concentrations within tissues, which
increases activity of GP to produce more glucose during freezing events. AVT may also
be enhancing beneficial water movements as several families of AQPs and GLPs in
freeze-tolerant tree frogs have also been shown to be regulated by both AVT and
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epinephrine, including the HC-3 GLP (Zimmerman et al., 2007; Ogushi et al., 2009;
Ratycz, 2014).
My results indicate that AVT and epinephrine have overlapping effects on
cryoprotectant production. Since both of these glycogenolytic responses are mediated by
cAMP, future work to measure cAMP fluctuations -especially after administration of the
AVT antagonist and/or propranolol - during freezing may help us understand the extent
AVT and epinephrine have on responses to freezing. Can glucose production be
suppressed to control levels when exposed to both AVT-antagonist and propranolol? How
is glycerol production and movement affected when exposed to various combinations of
AVT and epinephrine in tandem? Future work using both AVT and β-adrenergic
agonists/antagonists in various combinations might provide powerful insight into the
intermingled relationship of AVT and epinephrine affect amphibian freeze tolerance.
Overall, this is the first study to both confirm elevations in systemic AVT during
freezing in P. regilla and that cryoprotectant outputs are suppressed when AVT is
inhibited during freezing. Both provide useful evidence and offer more insight into
understanding the biochemical processes involved in freeze-tolerance.
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